Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (11)

2023

  1. Association of depression phenotypes and antidepressant treatment with mortality due to cancer and other causes: a community-based cohort study

    Frontiers in Psychology, Vol. 14

2022

  1. A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

    Cancers, Vol. 14, Núm. 12

  2. Antitumoral Effect of Plocabulin in High Grade Serous Ovarian Carcinoma Cell Line Models

    Frontiers in Oncology, Vol. 12

  3. Dostarlimab for the treatment of advanced endometrial cancer

    Expert Review of Clinical Pharmacology, Vol. 15, Núm. 1, pp. 1-9

  4. Prospective Real-World Gynaecological Cancer Clinical Registry with Associated Biospecimens: A Collaborative Model to Promote Translational Research between GEICO and the Spanish Biobank Network

    Cancers, Vol. 14, Núm. 8

2021

  1. Bevacizumab in recurrent ovarian cancer: could it be particularly effective in patients with clear cell carcinoma?

    Clinical and Translational Oncology, Vol. 23, Núm. 3, pp. 536-542

  2. SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 3

2020

  1. Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors

    Annals of Oncology, Vol. 31, Núm. 2, pp. 274-282

2019

  1. Myoinvasive pattern as a prognostic marker in low-grade, early-stage endometrioid endometrial carcinoma

    Cancers, Vol. 11, Núm. 12

2018

  1. Comparison of RNA-seq and microarray platforms for splice event detection using a cross-platform algorithm

    BMC Genomics, Vol. 19, Núm. 1

  2. High-throughput 3-dimensional culture of epithelial ovarian cancer cells as preclinical model of disease

    Oncotarget, Vol. 9, Núm. 31, pp. 21893-21903